wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33405150-140489F1-BE22-431F-B4AC-878FAE673214
Q33405150-140489F1-BE22-431F-B4AC-878FAE673214
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405150-140489F1-BE22-431F-B4AC-878FAE673214
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.
P2860
Q33405150-140489F1-BE22-431F-B4AC-878FAE673214
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405150-140489F1-BE22-431F-B4AC-878FAE673214
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afe6774ae628cfdc449c87c32a470dcf83f6fd0e
P2860
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.